Allogene Therapeutics Inc (ALLO)
Net Income Growth
16.23%
Quarterly · Period ending:
ALLO Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported16.23%period ending
Latest reported16.23%period ending
ALLO Quarterly Net Income YoY % (-1525350.00% → 16.23%)
Year-over-year change
High-resolution chart · PNG
ALLO net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 16.226% | |
| 28.6709% | |
| 35.2508% | |
| 37.55% | |
| 23.2301% | |
| 8.1031% | |
| 32.8467% | |
| -6.4315% | |
| 16.2485% | |
| 34.9792% | |
| 5.8937% | |
| 25.089% | |
| -5.9435% | |
| -25.1947% | |
| -26.6856% | |
| -6.3464% | |
| -5.4288% | |
| -141.8598% | |
| -9.1848% | |
| -18.1111% | |
| -16.3381% | |
| 39.3998% | |
| -12.3546% | |
| -30.476% | |
| -47.8408% | |
| -72.4815% | |
| -100.0393% | |
| -16.6402% | |
| 69.4274% | |
| -1,116.2495% | |
| -1,525,350% |